Cellular Aspects of Vasculitis--T Cell-mediated Aspects

Overview

Journal Springer Semin Immunopathol

Specialty Allergy & Immunology

Date 2001 Oct 10

PMID 11591103

Citations 1

Authors

M E GRIFFITH

C D Pusey

Affiliations

Soon will be listed here.

Citing Articles

Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them?.

Beauvillain C, Delneste Y, Renier G, Jeannin P, Subra J, Chevailler A Clin Rev Allergy Immunol. 2008; 35(1-2):47-58.

PMID: 18176846 DOI: 10.1007/s12016-007-8071-9.

References

KING W, Brooks C, Holder R, Hughes P, Adu D, Savage C . T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission. Clin Exp Immunol. 1998; 112(3):539-46. PMC: 1904981. DOI: 10.1046/j.1365-2249.1998.00615.x. View

Rasmussen N, Petersen J . Cellular immune responses and pathogenesis in c-ANCA positive vasculitides. J Autoimmun. 1993; 6(2):227-36. DOI: 10.1006/jaut.1993.1020. View

Moosig F, Csernok E, Wang G, Gross W . Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol. 1998; 114(1):113-8. PMC: 1905085. DOI: 10.1046/j.1365-2249.1998.00695.x. View

Bolton W, Innes Jr D, STURGILL B, Kaiser D . T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations. Kidney Int. 1987; 32(6):869-76. DOI: 10.1038/ki.1987.288. View

Brouwer E, Stegeman C, Huitema M, Limburg P, Kallenberg C . T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol. 1994; 98(3):448-53. PMC: 1534512. DOI: 10.1111/j.1365-2249.1994.tb05511.x. View

Muller G, Gebhardt M, Kompf J, Baldwin W, Ziegenhagen D, Bohle A . Association between rapidly progressive glomerulonephritis and the properdin factor BfF and different HLA-D region products. Kidney Int. 1984; 25(1):115-8. DOI: 10.1038/ki.1984.16. View

Mayet W, Schwarting A, Orth T, Duchmann R, Meyer zum Buschenfelde K . Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1). Clin Exp Immunol. 1996; 103(2):259-67. PMC: 2200350. DOI: 10.1046/j.1365-2249.1996.d01-626.x. View

Cockwell P, Howie A, Adu D, Savage C . In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int. 1998; 54(3):827-36. DOI: 10.1046/j.1523-1755.1998.00053.x. View

Paul C, Haas J, Schoenwald U, Truckenbrodt H, Bettinotti M, Bonisch J . HLA class I/class II interaction in early onset pauciarticular juvenile chronic arthritis. Immunogenetics. 1994; 39(1):61-4. DOI: 10.1007/BF00171799. View

10.

Huang D, Giscombe R, Zhou Y, Lefvert A . Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener's granulomatosis. J Rheumatol. 2000; 27(2):397-401. View

11.

Csernok E, Trabandt A, Muller A, Wang G, Moosig F, Paulsen J . Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum. 1999; 42(4):742-50. DOI: 10.1002/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I. View

12.

van der Woude F, van Es L, Daha M . The role of the c-ANCA antigen in the pathogenesis of Wegener's granulomatosis. A hypothesis based on both humoral and cellular mechanisms. Neth J Med. 1990; 36(3-4):169-71. View

13.

van der Geld Y, Huitema M, Franssen C, van der Zee R, Limburg P, Kallenberg C . In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG). Clin Exp Immunol. 2000; 122(3):504-13. PMC: 1905800. DOI: 10.1046/j.1365-2249.2000.01415.x. View

14.

Bradley J, Lockwood C, Thiru S . Endothelial cell activation in patients with systemic vasculitis. QJM. 1994; 87(12):741-5. DOI: 10.1093/oxfordjournals.qjmed.a068892. View

15.

Reynolds J, Tam F, Chandraker A, Smith J, Karkar A, Cross J . CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest. 2000; 105(5):643-51. PMC: 289170. DOI: 10.1172/JCI6710. View

16.

Muller G, Muller C, Markovic-Lipkovski J, Kilper R, Risler T . Renal, major histocompatibility complex antigens and cellular components in rapidly progressive glomerulonephritis identified by monoclonal antibodies. Nephron. 1988; 49(2):132-9. DOI: 10.1159/000185039. View

17.

Papiha S, Murty G, AdHia A, Mains B, Venning M . Association of Wegener's granulomatosis with HLA antigens and other genetic markers. Ann Rheum Dis. 1992; 51(2):246-8. PMC: 1005667. DOI: 10.1136/ard.51.2.246. View

18.

Rees A, PETERS D, Compston D, Batchelor J . Strong association between HLA-DRW2 and antibody-mediated Goodpasture's syndrome. Lancet. 1978; 1(8071):966-8. DOI: 10.1016/s0140-6736(78)90252-0. View

19.

Harrison L, Hafler D . Antigen-specific therapy for autoimmune disease. Curr Opin Immunol. 2000; 12(6):704-11. DOI: 10.1016/s0952-7915(00)00166-7. View

20.

Burns A, Fisher M, Li P, Pusey C, Rees A . Molecular analysis of HLA class II genes in Goodpasture's disease. QJM. 1995; 88(2):93-100. View